STUDIO
BioStock Investor Pitch: Alligator Bioscience
How is Alligator Bioscience preparing to move forward after FDA approval? CEO Søren Bregenholt presents the company, which develops tumour-directed antibodies, and gives us...
RECOMMENDED READING
Spago Nanomedical’s CEO: “huge commercial opportunities are unfolding”
Last week we saw the USD 2 billion buyout of Fusion Pharmaceuticals by AstraZeneca...
Alligator to maximise immuno-oncology innovation
With ongoing partnering discussion for the phase III trial with mitazalimab, Alligator Bioscience can...